N-(2-oxo-2-((2'-oxo-1,1,2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)amino)ethyl)-N-(2-(pyridin-3-yl)benzyl)-pivalamide

ID: ALA4874859

Chembl Id: CHEMBL4874859

PubChem CID: 164629033

Max Phase: Preclinical

Molecular Formula: C34H33N5O3

Molecular Weight: 559.67

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)C(=O)N(CC(=O)Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21)Cc1ccccc1-c1cccnc1

Standard InChI:  InChI=1S/C34H33N5O3/c1-33(2,3)32(42)39(20-24-8-4-5-10-27(24)23-9-6-14-35-19-23)21-29(40)37-26-13-12-22-17-34(18-25(22)16-26)28-11-7-15-36-30(28)38-31(34)41/h4-16,19H,17-18,20-21H2,1-3H3,(H,37,40)(H,36,38,41)

Standard InChI Key:  QFNSOFQZJFHPBZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4874859

    ---

Associated Targets(Human)

ADM2 Tchem ADM2 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCB Tclin Calcitonin gene-related peptide 2 (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 559.67Molecular Weight (Monoisotopic): 559.2583AlogP: 5.15#Rotatable Bonds: 6
Polar Surface Area: 104.29Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.74CX Basic pKa: 4.75CX LogP: 5.04CX LogD: 5.04
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.34Np Likeness Score: -0.83

References

1. Zirimwabagabo JO, Jailani ABA, Avgoustou P, Tozer MJ, Gibson KR, Glossop PA, Mills JEJ, Porter RA, Blaney P, Wang N, Skerry TM, Richards GO, Harrity JPA..  (2021)  Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.,  64  (6.0): [PMID:33666424] [10.1021/acs.jmedchem.0c02191]

Source